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PREFACE 
 
 
 
This document presents the Massachusetts Department of 
Environmental Protection’s program for evaluating risks to human 
health and the environment from toxic chemicals in waters of the 
State. It is intended to serve as a guide to the applicable 
regulations, guidelines and procedures dealing with this topic for 
various types of waters in the State. It is not intended to 
replace or supersede any of the statutes or regulations in place, 
but rather to present in one place all the relevant public health 
and environmental protection portions of regulations, guidelines 
and methodologies used by the Department for protecting this 
invaluable state resource. 
                                                                2 
3 
 
1.0 INTRODUCTION 
 
 
 
The regulation and assessment of potential human health and 
environmental effects from chemicals in waters of the Commonwealth 
of Massachusetts are accomplished within the Department of 
Environmental Protection’s Bureau of Resource Protection and the 
Office of Research and Standards. The Office of Research and 
Standards is primarily responsible for evaluating the health and 
environmental risks posed by environmental contaminants, and for 
providing the Bureau with risk assessments necessary for regulatory 
decisions. In keeping with the Bureau’s goal of providing a 
coordinated approach to protecting the environment and citizens of 
the Commonwealth from potential adverse effects of chemicals in all 
types of water (surface water, groundwater, marine waters), this 
document is presented as a guide to the diverse programs that the 
state has for regulating toxic chemicals in state waters. 
 
The document highlights the applicable legislation for each 
type of use of water or resource to be protected; it describes how 
standards and guidelines are derived for each case; and it presents 
the methodologies used to determine the hazard to humans or the 
environment posed by chemicals in these types of waters. In some 
cases, the Department has a well—developed methodology for deriving 
guidance or assessing health risks (e.g., drinking waters); and in 
others the criteria or standards developed by the federal 
government are the primary basis for control (e.g., protection of 
aquatic species in surface waters). Note that the final enforceable 
limits on contaminants in waters are determined by the evaluation 
methodologies presented in this report in conjunction with the 
appropriate regulations, policies, and guidelines issued by the 
Divisions within the Department. The federal programs are described 
in summary in-this document. Portions of the document will serve as 
statements of departmental policy on how guidance is derived and 
hazards are assessed and will also be issued as separate policy 
statements. 
 
 
The regulatory framework applicable to Commonwealth waters is 
presented in Figure 1.1. The standard of protection applied to 
these waters is to regulate for the most sensitive use of the 
resource for the class of water. The two major uses are for 
drinking waters and non—drinking water purposes. This guide is 
organized along this major division. 


                                                                6 
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2.0 DRINKING WATERS 
 
 
 
There are two components to the management of toxic chemicals 
in drinking waters in Massachusetts. One is the use and derivation 
of concentrations of the chemicals in water that serve as standards 
or guidelines. These are individual numbers generally intended to 
represent concentrations of the chemicals in water which, acting 
alone, should pose no adverse health threat to individuals using 
that particular water source for their domestic water needs for a 
lifetime. The second component is an evaluation methodology for 
determining the human health risk when chemicals are present in a 
water supply either singly or in combination. 
 
 
 
2.1 APPLICABLE LEGISLATION AND REGULATIONS 
 
 
 
Drinking water quality in the state of Massachusetts is 
regulated under the authority of the Safe Drinking Water Act (SDWA) 
of 1974. The 1986 amendments to the SDWA provide additional 
guidance on the regulation of toxic chemicals in drinking waters. 
This legislation delegates primacy to the state for the 
implementation and enforcement of the terms of the act. The state 
implements the SDWA under 310 CMR 22.0 of the Massachusetts 
Regulations. The U.S. EPA maintains a role in providing guidance 
and setting some standards for chemicals in drinking waters. The 
state may adopt these standards or enforce a more stringent 
standard of its own derivation. The first step in the federal 
standard—setting process is the development of Maximum Contaminant 
Level Goals (MCLGs). MCLGs are health goals set by EPA at levels 
which would result in no known or anticipated adverse health 
effects with a “margin of safety”. Federal standards are termed 
Maximum Contaminant Levels (MCLs). MCLs are enforceable -limits and 
are set as close to MCLGs as feasible. The process used to 
establish these numbers is described in FR 52:25690—25717, July 8, 
1987. 
 
While a modest number of chemicals are regulated at the 
present time and more are scheduled for regulation in coming years, 
many chemicals are not regulated by federal standards. The state 
has developed a methodology for deriving guidelines and standards 
for chemicals not federally regulated or for cases where the state 
determines that a chemical should be more stringently regulated 
than EPA recommends. This methodology for deriving guidance is 
described in Section 2.2 of this document. 
 
The state drinking water regulations (310 CMR 22.00) provide 
guidance on how the individual MCLs are to be enforced for public 
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water supplies. The MCLs are developed to consider the health 
hazard posed by each single chemical acting in isolation from other 
chemicals that may be present in the water supply. In order to 
provide for the situation where mixtures of chemicals are being 
dealt with, the state uses a contaminated water evaluation 
methodology for assessing compliance with standards and for 
assessing human health risks posed by mixtures of chemicals 
(Section 2.3). 
 
The Department of Environmental Protection’s (DEP’s) Division 
of Water Supply (DWS) uses the drinking water guidelines developed 
by the Office of Research and Standards (ORS) in conjunction with 
risk assessment information and recommendations from ORS to 
determine on a case by case basis the appropriate course of action 
at a water supply. This action may include closure, limited usage, 
or continued special monitoring of a water supply depending on such 
factors as the nature of the contamination, the magnitude of 
exceedance, the combination of contaminants present, and the length 
of exposure. 
 
 
 
2.2 GUIDANCE DERIVATION METHODOLOGY 
 
 
 
2.2.1 Preface 
 
 
A risk assessment approach is used for deriving guidance 
values for individual chemicals in drinking waters. The methodology 
for assessing possible health effects posed by mixtures of 
contaminants also employs a risk assessment approach and is 
described in Section 2.3. Both the possible carcinogenic and other 
physiological non—carcinogenic human health effects of chemicals in 
drinking water are evaluated as part of the guidance derivation 
procedure for individual chemicals. The sequence of steps followed 
in the procedure is outlined in Figure 2.1. For all chemicals, 
guidance is developed to be protective of the most sensitive known 
adverse health effect. The basic steps in the procedure described 
in the following paragraphs include: 
 
1) Toxicological evaluation of the chemical; 
 
2) For all chemicals, determination of an allowable daily 
intake of the chemical protective of non—carcinogenic 
effects (reference dose equivalent); 
 
3) For carcinogens, classification of the carcinogenic 
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status of the chemical, and estimation of the potency 
of the carcinogen; 
 
4) setting estimates of exposure to the chemical via drinking 
water (i.e., intensity, frequency and duration of 
exposure); 
 
5) Determination of the daily intake of the chemical which is 
20% of the allowable daily intake or reference dose 
equivalent and/or that dose associated with a specified 
level of excess lifetime cancer risk; 
 
6) Determination of the feasibility of applying the numerical 
standard derived. 
 
 
 
2.2.2 The Risk Assessment Approach 
 
 
The risk assessment methodology for developing drinking water 
guidance follows generally accepted procedures (EPA, 1987; NJ 
Drinking Water Quality Institute, 1987; Cotruvo, 1988; Wisconsin 
DHSS, 1988). This process involves the characterization of the 
potential adverse health effects of human exposures to contaminated 
drinking water. 
 
A risk assessment generally consists of four major steps: 
hazard identification, dose—response assessment, exposure 
assessment, and finally, risk characterization. In the development 
of drinking water guidance for a particular chemical, all four 
steps are included, and risk management criteria are applied to 
derive the numerical guideline. The resultant guideline is the 
concentration of the chemical in drinking water which would not 
likely result in any adverse health effects over a lifetime’s 
exposure. Guidelines are health based, while standards may 
incorporate consideration of cost and feasibility of 
implementation. 
 
 
 
2.2.3 Toxicological Characterization 
 
 
The first step of the procedure is to identify the toxic 
effects that have been associated with a given chemical. Two major 
types of toxic effects are generally recognized: threshold (often 
called non—cancer) and non—threshold (often called cancer) effects. 
Virtually all chemicals exhibit threshold effects, while relatively 
few have been shown to exhibit non-threshold effects. This step 
corresponds to the hazard identification phase of the risk 
assessment procedure and is the process for determining what 
 11 
adverse health effects might be associated with exposure to a given 
substance. 
 
Four general classes of information may be used in this step: 
human epidemiological data and clinical case studies, animal 
bioassay data, data on in vitro effects of the chemical, and 
comparisons of molecular structure. Studies used in setting ORS 
drinking water guidelines are chosen to represent, as closely as 
possible, long—term human exposure to contaminated drinking water. 
Sound human data are therefore preferred. When human data are not 
available, studies in which animals were exposed via the oral route 
are preferred to those in which animals were exposed via inhalation 
or other exposure routes. Long—term exposures are preferred over 
shorter—term and acute exposures. 
 
Epidemiological studies that show a positive association 
between exposure to a chemical (preferably in drinking water) and a 
disease are accepted as the most convincing evidence for human 
health risk. However, very few epidemiological studies provide 
conclusive evidence of a cause/effect relationship. Also, most of 
the chemicals in the environment have not been studied with 
epidemiologic methods. These limitations necessitate a reliance on 
less direct evidence that a health hazard may be related to a 
chemical exposure. 
 
The most commonly available and relied upon data are those 
obtained from animal bioassays. The inference that results from 
animal experiments are applicable to humans is fundamental to 
toxicologic research. Summaries of animal bioassay studies are 
found in U.S. EPA Health Assessment documents, health advisories, 
and on the Integrated Risk Information System (IRIS) - a 
computerized data base maintained by the U.S. Environmental 
Protection Agency. The National Toxicology Program (NTP) 
publications, and the Agency for Toxic Substances and Disease 
Registry (ATSDR) publications are further sources of information. 
Preferred data come from chronic exposure studies, preferably 
ingestion studies. 
 
Short—term in vitro tests serve as another source of 
information. A positive response in a mutagenicity assay is 
supportive evidence that the agent tested is likely to be 
carcinogenic. Such data, in the absence of a positive animal 
bioassay, are rarely, if ever, sufficient to support a conclusion 
that a chemical is carcinogenic. But because short—term tests are 
rapid and inexpensive, they are valuable for screening chemicals 
for potential carcinogenicity and for lending additional support to 
observations from animal and epidemiologic investigations. 
 
The final source of hazard information used when epidemiologic 
and animal studies are insufficient or lacking, is the comparison 
of a chemical’s structure and activity with those of known 
carcinogens or other toxins. Structure and activity comparisons, 
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however, are used only as a last resort. This is because chemicals 
are unique and experimental data support such associations for only 
a few structural classes. 
 
With knowledge of its toxicological characteristics, the non—
cancer and cancer effects of a chemical are evaluated. In both 
cases, a dose—response assessment is performed. This step 
corresponds to the second step of the risk—assessment procedure. 
Here, the relationship between a dose of a chemical and the 
incidence of an adverse health effect is identified. From this 
point, an allowable daily intake or reference dose equivalent for 
non—carcinogenic effects and a potency factor for carcinogenic 
potential are derived, or adopted from IRIS. 
 
 
 
2.2.4 Reference Dose (RfD) Equivalent Derivation for Non-
Carcinogenic Health Effects 
 
 
Non—carcinogenic effects are those which are believed to occur 
only above some threshold dose. An Rfd equivalent is derived if an 
RfD is not available from IRIS. The RfD or RfD equivalent is an 
estimate of a sub—threshold human dose. Doses that are less than or 
equal to the reference dose are not likely to be associated with 
any adverse health effects. The RfD is an estimate of the daily 
dose of a chemical that a human may be exposed to without incurring 
any appreciable risk of an adverse health effect during their 
lifetime. 
 
The first step in the derivation of an RfD or RfD equivalent 
is the identification of a No Observed Adverse Effect Level 
(NOAEL), or in the absence of a NOAEL, a Lowest Observed Adverse 
Effect Level (LOAEL). Ideally, a NOAEL should be identified in the 
most sensitive test population, and should reflect a dose at and 
below which no adverse effects are likely after chronic oral 
exposures. If several species are tested, the most sensitive 
species is that which exhibits adverse health effects at the lowest 
doses (i.e. has the lowest NOAEL). If several studies are performed 
on the species identified as the most sensitive, the highest NOAEL 
is chosen for derivation of the RfD. If a chronic oral NOAEL cannot 
be identified from the toxicological literature, a chronic LOAEL 
may be used. If chronic oral exposure studies are unavailable, then 
subchronic studies are the next choice. The human RfD or equivalent 
is estimated by extrapolating the results of animal studies to the 
human condition. 
 
The RfD is derived by dividing the NOAEL (or LOAEL if a 
suitable NOAEL is not available) for subchronic or chronic exposure 
by one or more uncertainty factors (UF) times a modifying factor 
(MF): 
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RfD = NOAEL or LOAEL 
UF x MF 
 
 
The uncertainty factor used in calculating the RfD reflects 
scientific judgement regarding the various types of data used to 
estimate RfD values. An uncertainty factor of 10 is usually used to 
account for variation in sensitivity within the human population. 
An additional 10—fold factor is used for each of the following 
extrapolations: from long—term animal studies to the case of 
humans; from a LOAEL to a NOAEL; and from a subchronic study to a 
chronic study. In order to reflect professional assessment of the 
uncertainties of the study and database not explicitly addressed by 
the above uncertainty factors (e.g. completeness of the overall 
database), an additional modifying factor ranging from 1 to 10 is 
applied (U.S. EPA, 1989. Health Effects Assessment Summary Tables.) 
 
 
 
2.2.5 Potency Determination for Carcinogens 
 
 
2.2.5.1 Carcinogen Classification Procedure. Carcinogens are 
classified on the basis of the strength and type of evidence for 
carcinogenicity. The categorization scheme used places chemicals 
into five groups, A — E (U.S. EPA, 1986) as shown in Table 2.1. 
These groups are then reassigned to one of three categories where 
drinking water is being addressed (U.S. EPA, 1985). 
 
Category I includes Groups A and B, i.e., those chemicals 
which are known or probable human carcinogens with strong evidence 
of carcinogenicity. Category II includes Group C, those chemicals 
with equivocal evidence of carcinogenicity. Category III includes 
Groups D and E, which are generally considered noncarcinogens 
because of either no, nonpositive or inadequate evidence of 
carcinogenicity. Those chemicals in Category II with equivocal 
evidence of carcinogenicity are treated as noncarcinogens (using 
procedure described in Section 2.2.4) with an additional 
uncertainty factor of 10 applied to account for their unclear 
carcinogenic status. In most cases, Category III chemicals can only 
be evaluated for noncarcinogenic effects. 
 
 
2.2.5.2 Carcinogen Potency Determination. Carcinogenesis is 
assumed to have no threshold; i.e., exposure to any concentration 
of a carcinogen is assumed to be associated with some finite 
probability of tumor formation. The potency of the chemical is 
determined from the dose—response data. The potency is the cancer 
risk associated with a dose of 1 mg/kg/day, or in more general 
terms, the risk per unit dose (slope of the dose response curve). 
 TABLE 2.1 U.S. EPA CATEGORIZATION OF WEIGHT OF EVIDENCE 
FOR HUMAN CARCINOGENICITY* 
 
 
 
 
 
GROUP CLASS DESCRIPTION 
A Human Carcinogen Sufficient evidence from human 
epidemiological studies. 
B Probable Human -
Carcinogen, 
GROUP Bl: Limited evidence from human 
epidemiological studies. 
GROUP B2: Sufficient evidence from 
animal studies and inadequate or no 
data from human epidemiological 
studies. 
C Possible Human 
Carcinogen 
Limited evidence of carcinogenicity 
from animal studies in the absence of 
human data. 
D Not Classifiable 
As To Human 
Carcinogenicity 
Inadequate human and animal evidence 
carcinogenicity or no data available.
E Evidence of Non— 
carcinogenicity 
for humans 
No evidence for carcinogenicity in at 
least two adequate animal tests or in 
both adequate human epidemiological 
and animal studies. 
 
*Source: FR51:33992—34003. September 24, 1986. 
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Quantitative carcinogenic risk assessments are performed for 
chemicals in Category I (Groups A and B), and on a case—by-case 
basis for chemicals in Group C. Cancer risk and potency factors are 
estimated through the use of mathematical extrapolation models, 
most commonly the linearized multistage model, for estimating the 
largest possible linear slope (within the 95% confidence limit) at 
low extrapolated doses that is consistent with the data. The cancer 
potency or risk is characterized as an upper—bound estimate: 
i.e., the true risk to humans, while not identifiable, is not 
likely to exceed the upper-bound estimate, and may in fact be 
lower. The units of oral potency factors are usually in the form 
of risk per mg/kg/day of the chemical or (mg/kg/day)-1. 
 
 
 
2.2.6 Derivation of Drinking Water Guidance Concentrations 
 
 
The human reference doses or cancer potencies determined above 
are next used to identify allowable concentrations of contaminants 
in drinking water. Allowable concentrations yield a dose no greater 
than 20% of the oral reference dose and a dose associated with a 
lifetime cancer risk equal to one in one million respectively. 
Dose—response information is used with drinking water exposure 
information to derive the allowable concentrations. The process of 
measuring or estimating the intensity, frequency, and duration of 
human exposure to a chemical through drinking water ingestion is 
the third step of the risk assessment process: 
exposure assessment. The standard assumptions used by U.S. EPA and 
by ORS are: 
 
Lifetime average bodyweight: 70 kg 
Lifetime average ingestion rate: 2 liters drinking water/day 
Relative source contribution from drinking water: 20% 
 
 
The relative source contribution factor of 0.2 comes from the 
assumption that only 20% of the daily exposure to compounds comes 
from water and that the remaining 80% of exposure would result from 
other sources such as air or food (U.S.EPA, 1985). 
 
 
The health based guidance level protective of non—carcinogenic 
effects is calculated as follows: 
 
 
 
mg/L in water = oral RfD (mg/kg/day) x 70 kg x 0.2 
2 L/day 
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The drinking water guidance considered protective of 
carcinogenic health effects is chosen to be that concentration of a 
compound associated with an excess lifetime cancer risk of one in 
one million (1x10-6). One in one million represents an extremely 
small additional lifetime cancer risk, and an increased incidence 
of this magnitude is not measurable in a population by 
epidemiological techniques (N.J. Drinking Water Quality Institute, 
1987). This risk level is insignificant when compared with the 
estimate that about 76 million Americans now living will eventually 
have cancer; or about three in ten according to present rates 
(American Cancer Society, 1989). Therefore, an estimated increased 
lifetime cancer risk of one in one million is regarded as an 
acceptable and insignificant additional risk from a single 
contaminant. 
 
To derive the risk specific concentration of a carcinogen in 
drinking water, the specified level of risk is multiplied by 70 kg 
and divided by the oral potency factor and by 2 L/day: 
 
 
 mg/L in water = l x 10-6 x 70kg 
 
 
oral P.F. (mg/kg/day)-1 x 2 L/day 
 
 
 
 
The derivation of the health-based guidance is in essence the 
risk characterization step of a risk assessment. The guidance value 
is that concentration of a chemical that is not anticipated to be 
associated with any adverse health consequences in exposed 
populations. 
 
Drinking water guidance for individual chemicals is based 
primarily on the health effects posed by ingestion. Use of drinking 
water for purposes other than drinking, especially bathing, may 
also allow contaminants to enter the body through inhalation and/or 
skin absorption. Future guidance values may include an evaluation 
of these routes of exposure. Current guidelines are set at values 
believed to be protective of other routes of exposure. On a 
chemical—specific basis, other routes of exposure are examined if 
there is reason to believe that ingestion is not the primary route 
of toxicity. 
 
 
 
2.2.7 Final Determination of Appropriate Guidance Concentrations 
 
 
Health—based guidelines are the lower of two possible 
concentrations: 1) the concentration which could be associated with 
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cancer risks (due to lifetime ingestion of contaminated water) of 
no more than one in one million, or 2) the concentration which is 
associated with twenty percent of the reference dose for non— 
carcinogenic effects. ORS guidelines for noncarcinogens are set at 
concentrations which shall eliminate within the limits of 
practicability and feasibility, all adverse physiological effects 
which may result from ingestion of contaminated water. ORS uses 
twenty percent of the non—carcinogen oral reference dose to develop 
this guidance. 
 
If the lower of these two concentrations is not a feasible 
level for detection purposes, and therefore impractical from an 
enforcement viewpoint, the ORS guideline is then based on the 
practical quantitation level (PQL). PQLs are defined as the lowest 
levels that can be reliably achieved within specified limits of 
precision and accuracy of the analytical results during routine 
laboratory conditions (FR 54 No 97 May 22, 1989). These limits are 
plus or minus 40% of true value for concentrations less than 0.010 
mg/L and plus or minus 20% of true value for concentrations greater 
that 0.010 mg/L. In all cases addressed so far, guidance values for 
chemicals without evidence of carcinogenicity are entirely health—
based, i.e. the PQLs for these compounds are below the non— 
carcinogenic health—based guideline. For some carcinogens, however, 
final guidance has been set at the PQL. In these cases, the 10-6 
risk-based concentration is below the PQL for that compound. Every 
effort is made to ensure that the ORS guidelines for carcinogens 
are set as low as practicably feasible. 
 
 
The nominal residual cancer risks that are theoretically 
associated with exposures at the PQLs are examined, and a decision 
is made whether they are acceptable from a safety standpoint. 
Exceptions to these decision criteria include those carcinogenic 
compounds with public health benefits (e.g., disinfecting agents), 
or where natural concentrations of the chemical are above the 
health based guidelines and widespread treatment is impractical. In 
some instances, a risk—benefit analysis is performed. 
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2.3 CONTAMINATED DRINKING WATER EVALUATION 
 
 
 
2.3.1 Applicable Situations 
 
 
Several approaches are used in DEP to evaluate the potential health 
hazard posed by toxic chemicals in drinking waters. These 
approaches are dependent upon the availability of standards or 
guidelines for comparison. The alternatives are discussed in each 
of the following subsections. 
 
The decision alternatives recognize that the basis for control of 
drinking water quality is the federal system of MCLs for individual 
chemicals. These numbers are derived to be protective of public 
health on an individual chemical basis and incorporate some 
consideration of feasibility of implementation and cost. When the 
situation arises where standards or guidelines are not available 
for all chemicals in a water supply, then a risk assessment 
approach is used for the evaluation of mixtures of chemicals. In 
some cases, even when standards or guidelines are available for the 
chemicals present in the mixture, a risk assessment is performed. 
 
 
 
2.3.2 Decision Alternatives 
 
 
The decision process for evaluating health hazards from toxic 
chemicals in drinking waters is presented in Figure 2.2. The 
process involves comparing the chemical composition data for the 
water supply to a list of standards and guidelines for the state. 
The possible outcomes of this comparison along with actions taken 
are illustrated in Figure 2.2. 
 
 
2.3.2.1 All Chemicals With Standards or Guidelines. In cases where 
guidance (standard or guideline) is available for all chemicals in 
a drinking water source, the concentration of each chemical is 
compared to the respective guidance level for that chemical. 
Exceedances of MCLs are identified according to the guidance 
contained in 310 CMR 22.06, 22.07, and 22.09. 
 
In cases where all chemical concentrations are less than the 
guidance, a water system may be judged to pose no unacceptable 
human health hazard. However, the characteristics of the chemicals 
occurring together are considered: the toxicological nature of each 
compound; its concentration in the water; and its proximity to the 
guidance value. In cases with mixtures where all or most chemical 
concentrations are slightly below the guidance concentrations, or 
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some chemicals are of particular concern, then it is recognized 
that these chemicals may act in concert to exert an effect greater 
than that exerted by any one of them individually. In this case, a 
risk assessment (Section 2.3.3) may be performed to quantify the 
potential carcinogenic and non—carcinogenic health hazard posed by 
the mixture of chemicals acting together. 
 
If the concentrations of one or more of the chemicals in a 
supply are greater that their respective guidance values, the 
situation may be sufficient to deem the water source unacceptable 
(i.e., MCL exceedance) according to 310 CMR 22.06 and 22.07. A risk 
assessment is then performed to assess the type and level of risk 
posed by the chemicals. The risk assessment provides information 
that can then be used as the basis for management decisions about 
appropriate action or clean—up according to the risk management 
criteria presented in Section 2.3.7. of this document and policies 
and procedures of DEP’s Division of Water Supply. 
 
 
 
2.3.2.2 Some Chemicals Without Standards or Guidelines. When this 
situation exists, it is possible for some of the chemical 
concentrations to exceed MCLs and to have the water source deemed 
unacceptable according to 310 CMR 22.06 and 22.07. However, in 
order to provide risk management guidance and incorporate 
consideration of the potential health effects of all chemicals in 
the mixture, a risk assessment is performed on the chemicals in the 
mixture. The assessment addresses both threshold—type and non— 
threshold-type effects. Risk management criteria described in 
Section 2.3.7 are used to evaluate the degree of human health 
hazard posed by the chemical mixture. 
 
 
 
2.3.3 Risk Assessment 
 
 
The risk assessment approach used for evaluating the possible 
health risks from contaminated water supplies takes into 
consideration the possible additive effects from multiple 
contaminants and multiple exposure routes (ingestion, dermal 
absorption, and inhalation.) The risk management criteria used to 
decide what remedial actions should be considered are described in 
Section 2.3.7. 
 
The risk assessment process consists of the following 
components 
 
i. comparing ingested, inhaled and dermal intakes (Average 
Daily Dose) of individual contaminants to Reference Doses 
(which represent allowable daily intakes considering only 
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threshold effects); 
 
ii. estimating the likelihood of threshold effects due to the 
combined effects of ingestion, inhalation and dermal 
absorption for all the contaminants in a supply or well. 
This assessment is made using a Hazard Index approach; 
 iii. estimating total excess lifetime cancer risks 
corresponding to ingested, inhaled and dermal intake for 
each of the contaminants in a supply or well; 
 iv. estimating total excess lifetime cancer risks 
corresponding to ingestion, inhalation and dermal 
absorption for all the contaminants in a supply or well. 
 
 
 
2.3.4 Estimation of Average Daily Dose (ADD) for Drinking Water 
 
 
The estimation of the average daily dose of a chemical that an 
individual receives through ingestion of water, inhalation and 
dermal absorption is one component of the assessment of the health 
hazard of a chemical. This number may then be compared with a 
concentration deemed to be acceptable for lifetime exposure to 
estimate the relative likelihood of the occurrence of adverse 
health effects. 
 
An individual’s Average Daily Dose from a source of drinking 
water is the sum of the ADDs for ingestion of the drinking water 
(ADDdwi), dermal contact with the water (ADDdwd), and inhalation of 
volatilized contaminants from that water (ADDdwih): 
 
 
 
ADDdw = ADDdwi + ADDdwd + ADDdwih 
 
 
 
where: 
 
ADD  dwi: ADD from Ingestion of Contaminated Drinking Water: 
 
 
 
 
ADDdwi  = [Cont]dw * VI * BAF * D2 * C 
 
      BWavg * AP 
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where: 
 [Cont]dw = Representative concentration of contaminant in 
   the drinking water (dimensions: mass/volume) 
 
 VI = Daily volume of drinking water ingested 
   (dimensions: volume/time) 
 
 BAF = Bioavailability Adjustment Factor 
  = Duration of the exposure period (dimension: 
time) 
 BWavg = Average body weight of the receptor of concern 
   during the averaging period 
       (dimension: mass) 
 
 AP = Averaging Period (dimension: time) 
 
C =     Appropriate units conversion factor(s). 
 
 
ADD  dwd: ADD from Dermal Contact with Contaminated Drinking Water: 
 
 
 
 
ADDdwd = [Cont]dw * SA * PC * BAF * F * D1 * D2 * C 
 
BWavg * AP 
 
 
 
where: 
 
 [Cont]dw = Representative concentration of contaminant(s) in the 
drinking water (dimensions: mass/volume) 
 
 SA =    Skin surface area in contact with the surface water 
       during the period of exposure. (dimension: area) 
 
 PC =    Permeability Constant (dimensions: 
       volume/time*area) 
 
 BAF  =    Bioavailability Adjustment Factor 
 
 F = Number of exposure events during the exposure 
   period divided by the number of days in the 
   exposure period (dimensions: events/time) 
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 D1 = Average duration of each exposure event (dimensions: 
   time/event) 
 
 D2 = Duration of the exposure period (dimension:time) 
 
BWavg = Average body weight of the receptor of concern during 
the averaging period (dimension: mass) 
 
 AP = Averaging Period (dimension:time) 
 
 C = appropriate units conversion factor(s) 
 
 
 
 
 
ADD  dwih: ADD for Inhalation of Contaminants from Drinking Water 
 
 
 
 
 
 
 
 
 
 
Where: 
 
[Cont]air = Representative concentration of gaseous 
chemical contaminant in the air during 
the period of exposure (dimensions: 
mass/volume) 
 
VR       = Daily respiratory volume for the receptor 
of concern during the period of exposure. 
(dimensions: volume/time) 
 
BAF      = Bioavailability Adjustment Factor 
 
F        = Number of exposure events during the 
exposure period divided by the number of 
days in the exposure period (dimensions: 
events/time) 
 
           D1       =      Average duration of each exposure event 
(dimensions: time/event) 
 
           D2          =      Duration of the exposure period 
(dimension: time) 
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BWavg Average body weight of the receptor of 
concern during the averaging period 
(dimension: mass) 
 
AP Averaging Period (dimension: time) 
 
C Appropriate units conversion factor(s) 
 
 
Dermal absorption and inhalation of chemical contaminants may 
occur while an individual is in contact with the drinking water. 
Typically these exposures would take place during showering, 
bathing, washing dishes, cooking and other household activities. 
The Average Daily Dose received via inhalation exposures and dermal 
absorption from drinking water during household activities (ADDdwih and ADDdwd) may be calculated using the equations presented. If information sufficient for calculating ADDdwd and ADDdwih are not available, default exposure assumptions as described in Section 
2.3.5 may be used. 
 
 
 
 
2.3.5 The Hazard Index: Assessing Potential for Non—Cancer 
Effects. 
 
 
In order to assess the degree of potential health threat posed 
by the calculated average daily dose (ADD) for each chemical in the 
mixture, each ADD is divided by the respective RfD or RfD 
equivalent for each chemical. These individual hazard indices (HI) 
can then be summed to provide an estimate of the likelihood of 
threshold-type health effects for the mixture of chemicals. 
 
The hazard index is an additive model recommended for systemic 
toxicants (U.S EPA, 1986). Several studies have demonstrated that 
dose additive models often predict reasonably well the toxicities 
of mixtures composed of a substantial variety of both similar and 
dissimilar compounds (EPA FR 51:34013—34025, 1986). Dose addition 
is not the most biologically plausible approach if the compounds do 
not have the same mode of toxicologic action. Therefore, the 
assumption of dose addition is most properly applied to compounds 
that induce the same effect by similar modes of action. 
 
A separate hazard index should be generated for each end—point 
of concern and for each exposure route of concern (ingestion, 
inhalation, and dermal absorption). Therefore, as an example, the 
Ingestion Hazard Index for a mixture of contaminants with the same 
mechanism of toxic action is calculated as follows: 
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where: 
 
ADD1 the average daily dose from ingestion for the ith chemical in the mixture; 
 
RfDi EPA verified Reference Dose in mg/kg/day for the ith chemical in the mixture; 
 
In order to account for the exposures to volatile organic 
compounds via dermal absorption and inhalation, the Average Daily 
Dose received via dermal absorption (ADDdwd) and via inhalation 
(ADDdwih) are calculated as noted in Section 2.3.4. 
 
The hazard index provides a rough measure of the likely 
toxicity and requires cautious interpretation. Generally, as the 
hazard index approaches unity, concern for the potential hazard of 
the mixture increases. For this reason a risk management decision 
has been made which places the acceptable non—carcinogenic hazard 
index limit at 1. 
 
The hazard indices calculated for each exposure route and for 
each group of similar compounds are compared to the total non— 
carcinogenic risk limit of 1. 
 
Currently, there are no dermal reference doses or reference 
dose equivalents. There are a few inhalation reference doses 
published in EPA’s Health Effects Assessment Summary Tables. When 
an EPA verified inhalation reference dose is not available, a DEP 
Allowable Threshold Concentration (ATC) may be used for air 
exposures. The ATC values are adjusted Threshold Effects Exposure 
Limits (TELS) as presented in Chemical Health Effects Assessment 
Methodology and Method to Derive Allowable Ambient Limits (MA DEP, 
1990). The Allowable Threshold Concentrations may be used to derive 
reference dose equivalents in the following manner: 
 
  
RfD-equivalent (inh) = ATC * 10 m /day * 1/20 kg * C 
 
 
 
Where: 
 ATC = The Allowable Threshold Concentration 
 10 m3/day = Average Child Ventilation Rate 
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1/20 kg = Inverse of the Average Child Body Weight 
 
C = Units Conversion Factor 
 
 
In situations where there is not sufficient information to 
calculate dermal and inhalation doses of chemical contaminants 
associated with household use of drinking water, some assumptions 
can be made about the contribution of these two exposure routes. 
 
In general, unless there is evidence which indicates 
otherwise, exposures via inhalation are important only for volatile 
organic compounds. Inhalation exposures to nonvolatile organic and 
inorganic substances during household use of drinking water may be 
assumed to be zero. 
 
Shehata (1985), U.S. EPA Office of Toxic Substances (1985), 
and Andelman (1985) indicate that, at least for some volatile 
organic compounds, the magnitude of the inhalation exposures 
related to non—ingestion uses of contaminated water is at least 
equal to the magnitude of the exposures associated with drinking 
that water (adult 2 liters/day, child 1 liter/day). 
 
It has also been suggested that the magnitude of exposure via 
dermal absorption to certain VOCs during showering and bathing may 
be equivalent to the magnitude of exposures associated with 
drinking that water (adults: 2 liters/day, children: 1 liter/day) 
(Brown et al., 1984). Another study of the dermal absorption rates 
of 53 chemicals showed that dermal absorption was estimated to 
account for, at most, 25 percent of the exposure expected from 
ingestion of 2 liters of drinking water daily (Vanderslice n.d.) 
 
When there is insufficient information for direct calculation 
of doses of VOCs in drinking water via inhalation and dermal 
absorption, it may be assumed that the doses via ingestion, 
inhalation and dermal absorption are equivalent. This assumption 
may be incorporated into the equation for estimating the total 
Hazard Index. 
 
When inhalation and dermal RfDs or RfD—equivalents are 
unavailable, the total HI (ingestion, inhalation and dermal 
absorption) may then be estimated by three times the Ingestion 
Hazard Index: 
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2.3.6 Non-Threshold Effects Evaluation 
 
 
The risks associated with non-threshold health effects (i.e., 
carcinogenesis) are characterized by focusing on estimated Excess 
Lifetime Cancer Risk (ELCR) for the theoretical individual who 
spends his/her lifetime exposed to the contaminated drinking water. 
For an individual contaminant and for the ingestion route of 
exposure, the ELCR is calculated as shown below. The total cancer 
risk is calculated by summing the estimated excess lifetime cancer 
risks associated with the theoretical individual’s exposure, over 
the next 70 years, to each of the contaminants present in the 
drinking water. This approach includes the estimated lifetime 
cancer risks posed by each exposure route. The ELCR is the 
probability that an individual would develop cancer as a result of 
exposure to a given chemical. 
 
 
 
 
 
 
 
 
 
where: 
 
 LADDing  =  Lifetime average daily dose received via 
    ingestion of drinking water (mg/kg/day). 
  
          Potency =  the upper 95% confidence limit on the cancer 
                     slope value (mg/kg/day)-1. 
 
 
If information is not sufficient to estimate the cancer risks 
posed via the inhalation and dermal exposure routes (i.e. cannot 
estimate ADDdwih and ADDdwd, and there are no inhalation and dermal 
absorption potency factors for the contaminants in question), and 
it is assumed that the total dose via ingestion, inhalation, and 
dermal absorption is equal to three times the ingested dose, then 
the estimated ELCR due to ingestion, inhalation and dermal 
absorption of water containing a given chemical is assumed to be 
three times the ELCR due to ingestion alone. Note that this is a 
default exposure assumption, and that this factor may change as 
better information becomes available. 
 
 
  
  ELCRi =(3) X  ELCRi, ingestion  
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where: 
 
 ELCRi = the excess lifetime cancer risk 
   associated with ingestion, inhalation 
   and dermal absorption of chemical i; 
 ELCRi, ingestion = the excess lifetime cancer risk 
   associated with ingestion of chemical 
   i. 
 
 
In the case where a mixture of contaminants is present, the 
ELCR due to ingestion, inhalation and dermal absorption of all the 
chemicals present would equal the sum of the ELCRs (ELCRi) for each 
of the chemicals. For the evaluation of cancer risk for water 
supplies, the assumption is made that exposed individuals will be 
exposed to the same concentrations throughout their 70 year 
lifetimes. 
 
 
 
2.3.7 Risk Management Criteria for Mixtures of Chemicals in 
Drinking Water Supplies 
 
 
2.3.7.1 Threshold Effects. A Total Hazard Index greater than 1.0 
indicates the possibility of threshold effects resulting from 
longer term exposure to contaminated drinking water. A Total Hazard 
Index less than or equal to 1.0 indicates that threshold (non—
carcinogenic) effects would not be expected to occur as a result of 
exposure to the contaminated drinking water for any period of time. 
 
 
2.3.7.2 Non-Threshold Effects. ORS and DWS consider a total ELCR 
greater than 1 in 10,000 (1 x 10-4) an unacceptable risk. If, based 
on reported levels of contamination and an assumed lifetime 
exposure to the contaminated source, the total ELCR is greater than 
1 in 10,000, immediate closure of the well is recommended. 
 
A total ELCR greater than 1 in 100,000 yet less than 1 in 
10,000 (1 x 10-5 < ELCR < 1 x 10-4) is considered an unacceptable 
risk for long term exposure. Under certain conditions, limited 
short term use of the well or source may be allowed pending 
remedial action. Continued special monitoring of the source during 
this compliance period is recommended. 
 
A total ELCR less than 1 in 100,000 (1 x l0-5) is considered 
acceptable for long term use of the source, although regular 
monitoring should continue to ensure that contaminant 
concentrations remain low. 
 
The excess lifetime cancer risk of one in one hundred thousand 
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used as the “acceptable” limit when evaluating mixtures of 
contaminants in a water supply differs from the target risk level 
of one in one million used to derive guidelines for individual 
chemicals (as described in Section 2.2.6). Although this may seem 
inconsistent, guidelines for individual chemicals are targeted at a 
lower risk limit than the acceptable risk limit for mixtures of 
contaminants for the following reason. Drinking water guidelines 
may often be used by those outside ORS in lieu of a risk assessment 
when more than one chemical is present in a water supply. The 
situation could occur where a mixture of chemicals was present, 
each at or below its respective guidance concentration, and the 
total ELCR for the mixture could be sufficiently high to be of 
concern. In order to minimize the possibility of this happening, 
the individual target risk is set an order of magnitude below that 
for a mixture of chemicals. There will be some instances where a 
few chemicals may be present together at concentrations greater 
than their respective guidance levels and hence be at unacceptable 
concentrations when judged by that criterion; yet the total ELCR 
posed by the mixture is judged acceptable (i.e. less than or equal 
to 1 x 10-5 ELCR) when evaluated against the mixture risk criterion. 
Management decisions in these cases will be made by DWS and ORS. 
 
 
 
 
2.4 LIMITATIONS AND UNCERTAINTIES 
 
 
 
The procedures described above represent the most current 
approaches to guideline derivation and evaluation of hazards posed 
by chemicals in potable waters. Nevertheless, there are several 
shortcomings in the methodologies which should be noted. 
 
The relative source contribution factor in guidance derivation 
has standardly been used to account for other non—drinking water 
exposures to chemicals. In theory, this approach is valid, but in 
practice it is constrained by the nature of toxicological data 
generated in support of chemical hazard assessment. Adjustment of 
an exposure route—specific ingestion RfD to reflect exposures that 
may come from other exposure routes such as inhalation or dermal is 
constrained by the fact that the body’s capacity for detoxifying, 
sequestering or eliminating chemicals may differ between routes of 
entry into the body. Route-specific RfDs reflect the body’s 
capacity to handle chemicals introduced to it through that 
particular exposure route. There are no good estimates of the 
body’s overall capacity for chemical resistance through 
simultaneous multiple routes of exposure (RfDwhole body). The 
complexity of multiple route dosing has precluded generation of 
whole animal RfDs representing the systemic capacity to deal with 
chemical exposure. 
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The adjustment that is therefore made for relative source 
contribution in drinking water uses 20% as a lower default value 
and other chemical—specific values when available. 
 
Guidance and hazard evaluations are based upon lifetime 
exposures. Frequently the hazards from less than lifetime exposures 
are of interest and methods for assessing risks associated with 
these exposures have some limitations. Evaluation of non—
carcinogenic effects for less than lifetime exposures is possible 
because acceptable doses are based upon daily intake. However, 
exposure to carcinogens is evaluated over an entire lifetime. The 
understanding of the toxicological nature of tumor formation in 
relation to shorter—term exposures is incomplete and therefore it 
is not possible to quantitatively evaluate less than lifetime 
cancer risks with any degree of certainty. In cases where cancer 
risks from a contaminated water supply are judged to be acceptable 
(<10-4 — 10-5 ELCR) when the water is used on a short-term basis, ORS 
and DWS have chosen a maximum time of three years for this exposure 
to continue. This value is not based on empirical dose—response 
relationships, but rather reflects an appraisal of the maximum 
amount of time that might be required to design, construct and 
bring into operation remediation systems. In these cases, the goal 
should be to strive for the shortest periods of exposure possible. 
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3.0 NON-DRINKING WATERS 
 
 
 
The management of toxic chemicals in surface waters in 
Massachusetts focuses on the protection of public health and on the 
enhancement of the quality and value of the water resources in the 
state. These objectives are achieved through the use and derivation 
of concentrations of the chemicals in water that serve as 
guidelines. The guidelines are individual numbers generally 
intended to represent concentrations of the chemicals in surface 
waters which, acting alone, should pose no adverse health threat to 
humans, aquatic life or wildlife. 
 
The Massachusetts Surface Water Quality Standards contained in 
the Massachusetts General Laws provides the authority for the 
Department of Environmental Protection (DEP) to regulate non—
drinking waters. The Massachusetts Surface Water Quality Standards 
were last promulgated on July 20, 1990. 
 
 
 
3.1 AQUATIC LIFE PROTECTION 
 
 
3.1.1 Applicable Legislation 
 
 
The Massachusetts Surface Water Quality Standards apply to all 
classes of fresh and salt surface waters in Massachusetts including 
drinking waters as well as waters designated for primary and 
secondary contact recreation. These Standards, contained in 314 CMR 
4.00 of the Massachusetts General Laws, specify that at a minimum, 
all surface waters shall be free from pollutants in concentrations 
that are toxic to humans, aquatic life or wildlife. 
 
Section 4.05 (5)(e)(l) of the Massachusetts Surface Water 
Quality Standards authorizes the Department to use the recommended 
pollutant-specific limits published by EPA pursuant to Section 3.04 
(a) (1) of the Federal Clean Water Act, including criteria listed 
in quality Criteria for Water 1986 (EPA 440/5-86—001) (i.e., EPA’s 
“Gold Book”), to establish water quality based effluent 
limitations. In addition, where recommended limits are not 
available or are judged to be inapplicable to a particular 
situation due to site—specific physical, chemical or biological 
considerations, the Department is authorized by these regulations 
to use a site—specific limit which, at a minimum, should not exceed 
safe exposure levels determined by toxicity testing using 
Department—approved methods. 
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3.1.2 Overview 
 
 
The introduction of wastewaters into surface water bodies is 
regulated with surface water discharge permits. The DEP Division of 
Water Pollution Control (DWPC) uses the EPA criteria as well as any 
site—specific criteria to make determinations on a case by case 
basis as to effluent discharge limitations for surface water 
discharge permits. DWPC uses a combination of recommended limits 
and site—specific limits to make decisions based on its perception 
of the pollutants of concern and the potential impacts resulting 
from their presence. DWPC’s goals for the control of toxic 
pollutants in surface waters include the protection of human 
health, the protection of aquatic life and the prevention of 
bioaccumulation of toxic pollutants in sediments or biota, 
particularly fish and shellfish. 
 
 
 
3.1.3 U.S. EPA Water Quality Criteria For The Protection of 
Aquatic Life 
 
 
The U.S. EPA Water Quality Criteria for the protection of 
aquatic organisms are available for acute and chronic exposures to 
aquatic freshwater and marine organisms. The derivation of the 
ambient water quality criteria for the protection of aquatic life 
is a complex process initiated with an extensive literature review 
and collection of data relating to the toxicity to and 
bioaccumulation by aquatic organisms of the specific chemical under 
review. Minimum data requirements for both freshwater and saltwater 
are established to include information on a variety of 
representative species and families native to North America. Data 
are reviewed to eliminate studies conducted using inappropriate or 
invalid techniques. If data for a particular chemical are judged to 
be adequate, the following criteria are developed from this 
information: 
 
 
An acute toxicity value is developed to 
represent a maximum one—hour average 
concentration that should not result in 
unacceptable effects on aquatic organisms and 
their uses.  If appropriate, this 
concentration is related to a water quality 
parameter such as pH, salinity or hardness. 
 
A chronic toxicity value is developed to 
represent a maximum 4—day average 
concentration that should not pose 
unacceptable toxicity during long-term 
exposure. If possible, this concentration is 
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also related to a water quality characteristic 
as above. 
 
Data on toxicity to aquatic plants are reviewed to determine 
whether aquatic plants might be unacceptably affected at levels 
which are deemed acceptable to animals. Data on bioaccumulation of 
residues by aquatic organisms are also reviewed to determine 
whether concentrations of residues in edible species might exist at 
levels that are unacceptable to wildlife consumers of aquatic life 
or whether Federal Food and Drug Administration (FDA) criteria for 
fish are exceeded. All other available information is also reviewed 
to assess if there is any potential of any other adverse biological 
effect. 
 
For additional detail regarding the development of these 
guidelines, refer to the EPA Gold Book (Quality Criteria for Water, 
EPA, 1986) 
 
 
 
3.1.4 DEP Site-Specific Limits For The Protection of Aquatic Life 
 
 
In the absence of EPA recommended limits, or if conditions at the 
site are very different from those used to develop a recommended 
limit or criterion, site—specific limits are determined to evaluate 
the threat of harmful effects to aquatic organisms. For example, 
site—specific limits may be established to account for some unique 
aspect of the local situation such as background water chemistry or 
the presence/absence of particular water uses. These limits should 
not exceed safe exposure levels derived by toxicity testing using 
Department-approved methods. The DWPC has established 
recommendations for specific tests and methodologies for the 
measurement of acute and chronic toxicity. These recommendations 
are described below. 
 
 
 
3.1.4.1 DEP Toxicity Testing Requirements. Toxicity tests are a 
means by which the effects of a chemical or a complex effluent can 
be determined using living organisms. These tests measure the 
degree of response of an exposed test organism to a specific 
chemical or effluent. The advantages of such a test system are 
several: toxicity testing measures the response of organisms to a 
whole effluent as a mixture of chemicals, not to individual 
chemical constituents, permitting the assessment of additive, 
synergistic or antagonistic responses. The evaluation performed can 
be made very site—specific in that water from the site can be used 
for dilution, representing actual site conditions.    
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 The DWPC guidelines for toxicity testing specify that tests 
for both acute and chronic toxicity be conducted using at least two 
species of organisms (usually a vertebrate and an invertebrate). 
The specific tests recommended by the DWPC are listed below. 
 
 
Inland Waters 
 
Acute Tests 
 
o 48-hour Ceriodaphnia dubia static test 
o 48—hour Pimephales promelas static test 
 
 Chronic Tests 
 
o 7-day Ceriodaphnia dubia static renewal test 
 
o 7—day Pimephales promelas static renewal test 
 
 
 
Coastal and Marine Waters 
 
Acute Tests 
 
o 48-hour or 96-hour Mysidopsis bahia static test 
o 48—hour or 96—hour Cvprinodon variegatus static test 
 
Chronic Tests 
 
o 7—day Cvprinodon variegatus survival and growth test 
o 7-day Mennidia sp. survival and growth test 
o Arabacia punctata fertilization test 
o 7—9 day Champia parvula sexual reproduction test 
 
 
 
The results of the most sensitive test are used to determine the 
toxicity criteria. For chemicals which are known to bioaccumulate, 
more stringent limits than those required by the toxicity testing 
requirements may be set. 
 
 
3.1.4.2 Evaluation Methodology. The results of the toxicity testing 
are used to make decisions regarding discharge permit approval. The 
DWPC has the responsibility for evaluating and issuing National 
Pollution Discharge Elimination System (NPDES) permits for 
discharges to surface water (DWPC, February 23, 1990). 
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Permit approval depends upon the capacity of the receiving waters 
to dilute the incoming effluent to achieve acceptable levels in 
receiving waters. The dilution factor characterizing a body of 
water is determined by the flow rate of the receiving water and the 
flow rate of the discharge. Generally, the higher the dilution 
factor of the receiving water, the greater its potential to 
dissipate an effluent discharge. 
 
Usually there is a transition distance where the effluent 
concentration is diluted to the receiving water concentration. This 
area is called the mixing zone. The Surface Water Quality Standards 
allow chronic toxicity criteria to be exceeded within mixing zones 
as long as there is safe and adequate passage for swimming and 
drifting organisms to pass through without causing deleterious 
effects on their populations. Since such organisms are assumed to 
spend only a brief period of time in the mixing zone, and will not 
be in the zone long enough for chronic exposure, it is assumed that 
exposures are of an acute nature. Therefore, under some 
circumstances chronic toxicity criteria may be exceeded within a 
mixing zone, but under no circumstances may acute toxicity criteria 
be exceeded within the mixing zone. Outside of the mixing zone, 
both acute and chronic toxicity criteria apply. 
 
Calculation of receiving water concentrations outside of the 
mixing zone is conducted using dilution factors and assuming 
completely mixed conditions. 
 
To evaluate a discharge in terms of aquatic life protection, 
the DWPC identifies and defines several parameters: 
 
NOEC - No Observed Effect Concentration: the highest measured 
continuous concentration of an effluent that causes no 
observed acute or chronic effect on a representative 
standard test organism. 
 
RWC — Receiving Water Concentration: At critical conditions, the 
NOEC measured in percent must be greater than or 
equal to the RWC of effluent in percent by volume (NOEC > 
RWC). 
 
LC5O — The concentration of a substance (measured in percent for 
effluents) that is lethal to 50% of the test organisms; 
represents the degree of toxicity on an inverse 
logarithmic scale; is usually associated with an exposure 
time (e.g., 24, 48, 96 hours). 
 
T.U. - Toxic Unit:  T.U. = (l00/LC5O) 
  
critical conditions —  for inland rivers and streams: the lowest 
                       average flow for seven consecutive days to 
                       be expected once in ten years (7Q10) 
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                          — for lakes. ponds and marine waters: 
                              established case—by—case 
 
dilution factor           — (the dilution available to a particular 
                             effluent): the ratio of receiving  
                             water flow (Qr) plus the effluent flow 
                            (Qe) to the effluent flow 
 
          dilution factor = Qr + Qe 
                               Qe 
 
 The DWPC has established a policy for regulating toxic 
chemicals in surface waters entitled the “Massachusetts Water 
Quality Standards Implementation Policy for the Control of Toxic 
Pollutants in Surface Waters.” This policy establishes the 
following guidelines: The recommended limit to prevent against 
acutely toxic effects is 0.3 T.U. This value is based on an 
adjustment factor of one-third used to extrapolate the LC5O to an 
LC1 (concentration at which 1% of the test organisms die). In 
addition, the DWPC has established an end-of-pipe limit of 1.0 T.U. 
for dilution factors less than or equal to 100 and 2.0 T.U. for 
dilution factors greater than 100. 
 
 At dilution factors less than 10, effluent toxicity poses 
a high risk to receiving waters. These waters are considered water 
quality limited in that the effluent limit of 1.0 Toxic Unit may 
not be stringent enough to protect receiving waters. The Division 
requires both acute and chronic endpoints to be reported. Two 
limits apply to the effluent: 1) the chronic test should result in 
a No Observed Effect Concentration greater than or equal to the 
Receiving Water Concentration (NOEC ≥ RWC) and 2) the acute level 
should be less than or equal to 1.0 Toxic Unit (an LC5O ≥ 100%). 
 
 Dilutions from 10 — 100 have an effluent limit of 1.0 
Toxic Unit. In the lower portion of this range (from 10 - 20) 
waters may be water-quality limited if the specific toxicants 
involved have high acute to chronic ratios. Therefore, the Division 
requires chronic monitoring to assure that the effluent limitation 
is adequate. In the range of dilution from 20 - 100 chronic 
monitoring is not required. Waters with dilutions above 100 have an 
effluent limit of 2.0 Toxic Units. 
 
 Recommended methods for toxicity testing are presented in 
Table 3.1. Generally, the Division requires four (4) samples per 
year at dilutions less than or equal to 100. Each sample is tested 
with two (2) test species. At dilutions greater than 100, two 
samples per year are required.” 
 
 
 
 
 
 
  
 
37 
TABLE 3.1. WHOLE EFFLUENT TOXICITY REQUIREMENTS FOR NPDES 
PERMITS 
 
DILUTION FACTOR EFFLUENT LIMITS TESTING REQUIREMENTS 
< 10 NOEC > RWC 
1.0 Toxic Unit 
4 samples/year; 
2 species; 
Acute and chronic 
endpoints 
10 — 20 1.0 Toxic Unit 4 samples/year; 
2 species; 
Acute and chronic 
endpoints 
> 20 — 100 1.0 Toxic Unit 4 samples/year; 
2 species; 
Acute endpoint 
> 100 2.0 Toxic Unit 2 samples/year; 
2 species; 
Acute Endpoint. 
Notes: 1 Ratio of receiving water plus effluent flow to effluent 
flow at critical conditions: 
 
Or + Qe = dilution factor 
Qe 
 
2 Effluent limits apply to the total toxicity 
concentration prior to mixing with receiving water. 
Limits are in Toxic Units where: 
 
100 = Toxic Units 
LC5O 
 
and LC5O = Concentration lethal to 
50% of the test organisms 
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3.2 HUMAN HEALTH PROTECTION 
 
 
3.2.1 Fish Ingestion 
 
 
3.2.1.1 Applicable Legislation. The Massachusetts General Laws 
pertaining to Surface Water Quality Standards (314 CMR 4.00) grant 
the Massachusetts Department of Environmental Protection (DEP) the 
authority to regulate surface water quality. 
 
1.) Within that authority, section 314 CMR 4.05 (5)(e) of the 
Massachusetts General Laws gives DEP the authority to use United 
States Environmental Protection Agency (EPA) Ambient Water Quality 
Criteria (AWQC) as guidance in establishing discharge limits for 
surface water for individual pollutants not specifically listed in 
the regulations. 
 
2.) In the absence of an EPA-recommended limit for a specific 
pollutant or in cases where existing limits are considered invalid 
due to site—specific physical, chemical or biological 
considerations, the Division shall use a site-specific limit. 
Guidance for establishing site-specific limits shall at a minimum 
not exceed safe exposure levels determined by toxicity testing 
using methods approved by the Director of the Division of Water 
Pollution Control (DWPC) (4.05(5)(e)(l)). 
 
3.) Furthermore, 314 CMR 4.05 (5) (e) (2) specifies that 
human-health based guidance concentrations for drinking water be 
issued by the DEP Office of Research and Standards (ORS) with the 
goal of eliminating “ . . . within the limits of practicability and 
feasibility, all adverse effects which may result from the 
ingestion of, inhalation of or dermal contact with contaminated 
water.” 
 
4.) In addition, section 314 CMR 4.05 (5)(e)(3) specifies that 
where appropriate the Department shall use an additional margin of 
safety when establishing water-quality based effluent criteria “to 
assure that pollutants do not persist in the environment or 
accumulate in organisms to levels that: (a) are toxic to human or 
aquatic life; or (b) result in unacceptable concentrations in 
edible portions of marketable fish or shellfish or for the 
recreational use of fish, shellfish, other aquatic life or wildlife 
for human consumption.” 
 
 
The State uses a combination of approaches described below for 
assessing the toxicity of chemicals in fish to humans including the 
use of EPA Ambient Water Quality Criteria, the federal Food and 
Drug Administration (FDA) action levels and tolerances as well as 
health risk assessment. 
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3.2.1.2 Overview. Primary responsibility for regulating the 
safety of foods including fish in Massachusetts and for issuing 
fish consumption advisories resides with the Massachusetts 
Department of Public Health (DPH). Nevertheless, DEP’s Office of 
Research and Standards (ORS) is often asked to review results of 
fish contaminant monitoring studies conducted in Massachusetts to 
provide DEP with information on potential health risks. This 
information is used by DEP to control water quality. 
 
The evaluation of fish contaminant data by ORS is a 
relatively new function of the office. The methodologies for 
evaluating these data are evolving. The protocol described in this 
section is therefore subject to refinement over time to reflect 
improvements in the methodology. 
 
The ORS evaluation of the human health hazard posed by toxic 
chemicals in fish includes three separate components: 
 
1.) Comparison to Criteria Concentrations Calculated from 
U.S. EPA Ambient Water Quality Criteria and to ORS 
Guidelines 
- The first component uses U.S. EPA criteria or ORS guidelines 
by comparing reported concentrations of chemicals in fish 
tissue to criteria concentrations of the chemicals in fish as 
back-calculated from applicable EPA Ambient Water Quality 
Criteria (AWQC) for protection of human health via fish 
ingestion; 
 
2.) Comparison to U.S. FDA Criteria for Fish Ingestion - The 
second component involves a comparison of detected 
concentrations of contaminants in fish tissue to applicable 
action levels and tolerances developed by the FDA; 
 
 3.) Risk Assessment from Fish Ingestion - The third component 
is an evaluation methodology, similar to the methodology used 
to assess chemically contaminated drinking waters, for 
determining the human health risk when chemicals are present 
in fish tissue either singly or in combination. These three 
evaluation methods are all used by ORS to characterize health 
risks more completely and each is described in the following 
sections. 
 
 
 
3.2.1.3 Comparison to Criteria Concentrations Calculated 
from U.S. EPA Ambient Water Quality Criteria and to 
ORS Guidelines. 
 
A. Ambient Water Qualitv Criteria for the Protection of Human 
Health 
 
The EPA Ambient Water Quality Criteria (U.S. EPA, 1986) for 
protection of human health are available for two exposure 
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scenarios. The AWQC are estimates of the surface water 
concentrations that will not result in adverse health effects in 
humans exposed to chemicals through one of two exposure scenarios. 
One exposure scenario considers ingestion of drinking water and 
aquatic organisms. The other exposure scenario considers only 
ingestion of aquatic organisms. ORS uses the criteria developed 
using the latter exposure considerations, ingestion of aquatic 
organisms only, for its fish toxics evaluations. 
 
The exposure assumptions inherent in these criteria are that 
an individual with a lifetime average body weight of 70 kg consumes 
an average of 6.5 g of aquatic organisms daily for a 70—yr 
lifetime. For noncarcinogens, EPA applies standard exposure 
assumptions to an EPA RfD to derive acceptable daily doses. 
Bioconcentration factors for chemicals from water into fish are 
then used to calculate the AWQC concentrations in water. For 
carcinogens, EPA specifies a recommended water concentration of 
zero for the maximum protection of human health. However, EPA 
provides estimates of water concentrations corresponding to 
increased lifetime cancer risks of 1 x l0-7, 
1 x 10-6 and 1 x l0-5. 
 
DEP uses AWQC concentrations with bioconcentration factors to 
calculate Criteria Concentrations of toxic chemicals in fish 
tissue. For carcinogens, DEP uses the AWQC concentration 
corresponding to an Estimated Lifetime Cancer Risk (ELCR) of 1 x 
10-6. 
 
B. DEP Criteria Concentrations for Fish Calculated from AWQC 
 
In order to use the AWQC in the evaluation of fish toxics 
monitoring data, an estimate is made of the equilibrium 
concentration existing in the fish corresponding to the 
concentration in water at the AWQC level. 
 
This is done using the following relationship: 
 
 
[Cont]fi = BCFfish * [Cont]w * UCF 
 
 
 
where: 
 
[Cont]fi   = Criteria Concentration of a contaminant in fish 
(dimensions: mass/mass) 
  BCFfish = Fish bioconcentration factor (ratio of 
   the contaminant concentration in fish to 
   the contaminant concentration in water) 
 
  [Cont]w = Concentration of a contaminant in water 
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at the AWQC (dimensions: mass/volume) 
 
 UCF = unit conversion factor for water: 1 L/kg. 
 
 
 
This equation indicates that the fish tissue concentration of 
a compound is a function of the water concentration and of the fish 
Bioconcentration Factor (BCF) for that compound. BCFs are derived 
quantitatively by dividing the concentration of a material in one 
or more tissues of an aquatic organism by the average concentration 
in the solution in which the organism had been living. A BCF is 
intended to account only for net uptake directly from the water. 
The BCFs used by the EPA for deriving AWQC are presented and 
discussed in the EPA Ambient Water Quality Criteria documents for 
individual chemicals. BCF values for the same chemical can vary 
greatly between species of fish based on such factors as fish 
metabolic rate, excretion rate, stage of life cycle and lipid 
content. As a result, ORS will review the origin and basis for the 
BCF for a particular chemical used by EPA in the derivation of AWQC 
on a case—by—case basis to determine whether it is applicable to 
the particular situation being evaluated by ORS. 
 
The fish tissue Criteria Concentrations serve as guidelines. 
An evaluation using these criteria involves a comparison of 
detected concentrations of compounds in fish to the respective 
guideline level calculated above for that chemical. 
 
For chemicals for which AWQC do not exist, ORS may develop its 
own guidelines, based on the availability of adequate toxicity data 
(i.e., EPA Reference Doses and Cancer Potency Factors). The same 
assumptions as those used by EPA for developing the AWQC are used. 
Thus the ORS guidelines assume that an individual with an average 
body weight of 70 kg ingests contaminated fish for a period of 70 
yrs. However, to be consistent with its guideline-derivation 
policies in other media, ORS makes several refinements to the 
methodology used by EPA to develop AWQC. 
 
ORS develops guidelines for both average and maximum fish 
ingestion rates. The average ingestion rate assumed is 6.5 g/day, 
the same rate used by EPA in developing the AWQC. The maximum 
ingestion rate assumed is 132.0 g/day, based upon a study of fish 
ingestion rates by Foran et al., 1989 for freshwater fish. The two 
criteria are used to apply to scenarios involving very different 
frequencies of fish ingestion, from individuals who consume about 
1-2 fish meals per month to those who do subsistence-type fishing 
and may eat fish nearly every day (i.e., 18-27 meals per month). 
 
In addition, the ORS guidelines consider both carcinogenic and 
noncarcinogenic effects. EPA instead develops one AWQC number for 
an individual compound based on either carcinogenic or 
noncarcinogenic effects. EPA’s methodology to derive AWQC does 
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not account for both types of effects. Thus an AWQC based on 
threshold effects is not developed for a compound that is also 
carcinogenic. The ORS methodology on the other hand, develops a 
guideline based on carcinogenic effects and a separate guideline 
based on noncarcinogenic effects, and then chooses the lower of the 
two as the criteria concentration. 
 
 The ORS calculation may also include a relative exposure 
contribution (REC) factor for exposure via fish ingestion. A REC is 
a factor which is often applied in risk assessment calculations to 
estimate the percent contribution of a contaminant via a particular 
medium to total exposure. ORS has developed a preliminary 
methodology to develop relative exposure contribution factors for 
fish ingestion relative to total ingestion exposure. Since the 
toxicity assessment from ingestion of fish is ultimately based on 
oral Reference Doses (RfD) and since the REC is to be expressed as 
a percent of the RfD, RECs are being developed considering only 
ingestion exposures. This approach is in contrast to the EPA 
approach used in developing drinking water guidance which applies a 
relative source contribution factor of 20% to the oral RfD to 
account for the assumption that 20% of total exposure to a 
particular compound comes from drinking water exposures. In the 
absence of adequate exposure data for a chemical, ORS will use a 
default value of 20% as the REC. A preliminary methodology for 
deriving contaminant—specific fish relative exposure contribution 
factors is being developed by ORS. 
 
 A Bioavailability Adjustment Factor (BAF) is also included 
in the equation to account for differences in absorption 
efficiencies of contaminants via fish ingestion and via the 
exposure route used by EPA to derive the Reference Dose (RfD). In 
this way, the detected contaminant concentrations in fish can be 
more appropriately compared to the developed guideline. 
 
 Finally, the assumptions inherent in the AWQC are based on 
the average adult. Exposures by children are not considered. The 
ORS methodology allows for the development of guidelines based upon 
the parameters for a child. On an as—needed basis, adjustments can 
also be made to the AWQC to account for specific exposures 
involving children. 
 
 The following relationships describe the derivation of the 
ORS guidelines, based on noncarcinogenic and carcinogenic effects: 
 
for noncarcinogenic effects: 
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where: 
           CCfish =  Criteria Concentration in fish tissue 
   dimensions: mass/mass) 
           RECfish    =  Relative Exposure Contribution factor via 
                      fish ingestion (contaminant-specific) 
 
           RfD =  EPA Reference Dose (dimensions: mg/kg/day) 
 
           BAF  =  Bioavailability Adjustment Factor 
 
           BW      = average body weight of a human adult(70kg) 
  
           IRfish    = fish ingestion rate (6.5 g/day) 
 
 
*For a child an appropriate body weight should be used: 
(i.e., BW  = 20 kg) 
 
 
 
for carcinogenic effects: 
 
 
 
 
 
 
 
where: 
 
CCfish = Criteria Concentration in fish tissue 
dimensions: mass/mass) 
 
RECfish = Relative Exposure Contribution factor via 
fish ingestion (contaminant-specific) 
 
 
              CPF = EPA Cancer Potency Factor (dimensions:  
                          (mg/kg/day)-1 
 
BAF = Bioavailability Adjustment Factor 
 
BW = average body weight of a human adult (70 
kg) 
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IRfish = fish ingestion rate (6.5 g/day) 
 
 
The lower of the above two guidelines based on carcinogenic or 
noncarcinogenic effects is selected as the ORS guideline. Thus the 
ORS guideline is based on the most sensitive effect and accounts 
for both effects. 
 
As fish toxics evaluations are conducted and the criteria 
concentrations and guidelines discussed above are developed, a list 
of these criteria will be compiled by ORS. 
 
An evaluation of potential human toxicity involves a 
comparison of detected contaminant concentrations in fish to the 
above criteria. In cases where all chemical concentrations are less 
than their respective guideline values, it may be judged that 
ingestion of the fish being evaluated may pose no unacceptable 
human health hazard. However, a comparison to FDA criteria for 
those compounds for which these criteria exist is also made. In 
addition, because the AWQC may not be based on the most current 
toxicological data and because the cumulative exposure to mixtures 
of chemicals is important to evaluate, a risk analysis is also 
performed. 
 
 
 
3.2.1.4 Comparison to U.S. FDA Criteria for Fish Ingestion. The 
Food and Drug Administration (FDA) issues a list of legal action 
levels and tolerance values for a limited number of chemicals which 
apply to fish oil or to the edible portion of fish and shellfish in 
interstate commerce. 
 
FDA criteria are generally set as a result of a risk—balancing 
process. The economic costs and loss of dietary benefits from fish 
ingestion associated with more stringent regulations for the 
recreational and commercial fisheries in the U.S. are weighed 
against the severity of possible health effects of a particular 
chemical. As a result, the health risks associated with the FDA 
criteria values may be higher than target risk levels used as goals 
for acceptability within the Department of Environmental 
Protection. 
 
Evaluation using FDA numbers involves a comparison of detected 
concentrations of compounds in fish tissue to FDA criteria. Even in 
cases where all compound concentrations are below FDA criteria, 
health risks may be unacceptable to the state. This situation 
results from the fact that FDA criteria are not solely health—
based. The availability of FDA criteria for a limited number of 
chemicals also limits their usefulness. 
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3.2.1.5 Risk Assessment for Fish Ingestion. 
 
 
A. Description of Approach 
 
As with the evaluation of drinking water, ORS uses a risk 
assessment approach for evaluating public health risks from fish 
ingestion. The assessment addresses both threshold—type and 
nonthreshold—type effects and evaluates the degree of human health 
hazard posed by individual chemical contaminants as well as that 
posed by mixtures of contaminants. To assess the potential for 
threshold effects, a Hazard Index is calculated as discussed in 
Section 2.3.5. ORS’ current policy regarding mixtures is to use a 
dose additive model to assess the additive effects of a mixture’s 
individual components. As discussed previously, dose addition is 
not the most biologically plausible approach if the compounds do 
not have the same mode of toxicologic action. Thus separate hazard 
indices are calculated for compounds which produce similar 
toxicologic effects. To assess nonthreshold effects, the Estimated 
Lifetime Cancer Risk (ELCR) is calculated for the theoretical 
individual who spends his/her lifetime ingesting contaminated fish. 
The toxicologic endpoint of concern in this case is only one: 
cancer. The four—step risk assessment process (described in section 
2.3.3 - Risk Assessment of this document) including hazard 
identification, dose—response assessment, exposure assessment and 
risk characterization is followed. 
 
 
B. Calculation of Average Daily Dose 
 
Although the EPA AWQC discussed in 3.2.1.2 are also based on 
EPA toxicity values (RfDs and cancer potencies), the toxicological 
values used in developing the AWQC may not be the most current. The 
risk analysis approach is more flexible because it permits 
consideration of a range of ingestion rates, as contrasted with the 
national average fish consumption rate used in the derivation of 
AWQC. 
 
The estimation of the Average Daily Dose (ADD) of a chemical 
that an individual receives through ingestion of fish is only one 
component of the assessment of the health hazard of a chemical. The 
general equation used to estimate the daily dose is expressed as: 
 
              
      ADDfi = [Cont]  fi * IR  * BAF * D  2 * C 
                      BWavg * AP 
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where: 
 
   [Cont]fi = Representative concentration of 
  contaminant in fish (dimensions: 
  mass/mass) 
 
   IR       =  Daily fish ingestion rate 
  dimensions: mass/time) 
 
   BAF      =         Bioavailability Adjustment Factor 
 
   D2           =         Duration of the exposure period 
   (dimension: time) 
 
   C        =  Appropriate units conversion factor(s) 
 
   BWavg       =  Average body weight of the receptor 
   of concern during the averaging 
 period (dimension: mass) 
 
   AP       =  Averaging Period (dimension: time) 
 
 
 In the above equation, the concentration of contaminant in 
fish tissue ([cont]fi) should ideally be representative of the 
edible portion of the fish. However, when these data are 
unavailable, information on whole fish concentrations can be used. 
 
 In addition, where data are available for a particular 
site, the above estimate can be refined further by considering two 
additional factors. These are: 1.) the Cooking Loss factor (CD) 
- This factor is defined as the proportion of toxic contaminants 
remaining in the fish after cooking: this type of data is usually 
obtained from individual studies designed for this purpose; and 
2.) the Local Consumption factor (LC) - This factor is defined as 
the percent total fish consumption in an area which is derived from 
local recreational stock. When available, the LC is used to further 
characterize the nationally or regionally derived fish ingestion 
rate. The data represented by both of these factors are not 
typically available but will be used when possible to refine the 
estimate. 
 
 Finally, this equation reflects the basic calculation to 
estimate the average daily dose used in assessing noncarcinogenic 
effects. To calculate the Lifetime Average Daily Dose (LADD) used 
for assessing carcinogenic risks, the averaging period (AP) above 
is assumed to be 70 yrs and the duration of the exposure period is 
also assumed to be 70 yrs. 
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C. Methods to Assess Hazard 
 
The Hazard Index: Comparison of ADDfi with RfD 
 
The likelihood of potential non-cancer threshold-type health 
effects posed by a mixture of chemicals is evaluated with the 
hazard index approach, described in detail in Section 2.3.5. The 
ADD for each chemical is divided by its respective RfD and then 
these ratios can be summed to provide an estimate of the likelihood 
of threshold-type health effects for the mixture of chemicals in 
fish. A separate hazard index should be generated for each 
toxicologic endpoint of concern (i.e., with the same mechanism of 
toxicologic action). 
 
 
Non-Threshold Effects Evaluation 
 
The risks associated with non-threshold health effects (i.e., 
carcinogenesis) are characterized by focussing on estimated ELCR, 
described in detail in Section 2.3.6, for the theoretical 
individual who ingests contaminated fish for a lifetime. The total 
ELCR is calculated by summing the individual ELCR for each chemical 
existing in the fish. 
 
 
 
D. Risk Management Criteria 
 
ORS’ policy for managing risk is to try to achieve a situation 
in which no significant risk of harm to human health, public 
welfare, safety or the environment exists. However, site—specific 
and other factors may make attainment of this goal infeasible. ORS 
therefore sets the following guidelines for evaluating risks: 
 
Hazard Index (Threshold Effects) 
 
For evaluation of fish toxicity, a total HI greater than 1.0 
indicates the possibility of threshold (noncarcinogenic) effects 
resulting from longer term ingestion of fish. A total HI less than 
or equal to 1.0 indicates that threshold effects would not be 
expected to occur as a result of exposure to contaminated fish for 
any period of time. Based on the risks calculated, fish consumption 
advisory levels (using the same exposure assumptions) may be 
developed which specify the amount of fish that can be ingested 
safely, if any, without exceeding a defined level of risk. 
 
 
Non-Threshold Effects 
 
ORS generally considers a total ELCR greater than 1 in 10,000 
(1 x 10-4) to be an unacceptable risk, a total ELCR greater than 1 
in 100,000 yet less than 1 in 10,000 (1 x 10-4 > ELCR > 1 x l0-5) to 
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be an unacceptable risk for long-term exposure, and a total ELCR 
less than 1 in 100,000 (1 x l0-5) to be an acceptable risk. 
 
As specified above, for exposure through fish ingestion, fish 
consumption advisory levels may be determined through risk analysis 
to specify the amount of contaminated fish that can be ingested in 
order to remain within a defined range of risk. 
 
 
DEP also strives to be consistent in its application of risk 
management criteria across media or in different situations. 
Fulfillment of this objective when evaluating contaminants in fish 
is complicated by the facts that: some contaminants (e.g., PCBs) 
have widespread distributions and often occur in high 
concentrations in fish in the state; and ingestion of fish confers 
a nutritional benefit. 
 
 
 
3.2.1.6 Implications of Multiple Assessment Methodologies/Policy 
Development. Use of a multiple assessment methodology as 
described above permits evaluation of the hazard to humans from 
eating contaminated seafood products from several perspectives. No 
one method of evaluation has been chosen consistently over the 
others. 
 
The FDA criteria generally permit a higher body burden of 
contaminant in fish tissue than would be derived by the other two 
methods. These criteria are available for only a few chemicals 
which limits the scope of their usefulness. In addition, the 
criteria have been developed to apply to fish in the marketplace 
and they reflect the fact that the average consumer probably 
receives his/her fish from a variety of sources and some higher 
concentrations of contaminants in some fish bought by that consumer 
will probably be offset by lower concentrations in other fish from 
the marketplace. On the other hand, recreational and subsistence 
fishermen who may derive a large part of their diet from fish from 
one localized area may not be adequately protected by these 
criteria. DEP is usually faced with evaluating the hazards posed to 
the public as a result of localized contamination, rather than 
evaluating fish in the marketplace. 
 
As a result of the way in which FDA criteria are set, the 
human health hazard posed to some consumers as a result of 
ingesting fish with some contaminants at the FDA action level is 
greater than the Department would normally allow under other 
circumstances. 
 
Criteria concentrations calculated from U.S. EPA Ambient Water 
Quality Criteria for fish ingestion present greater flexibility for 
assessment of site—specific related health risks. Carcinogenic and 
non—carcinogenic health effects, the relative magnitudes of doses 
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received from fish versus other sources of exposure to the chemical 
and exposures to children can be taken into consideration. It is 
however recognized that the EPA criteria were derived several years 
ago and may not therefore contain the most current estimates of the 
toxicological action of some chemicals. 
 
A risk assessment provides all the flexibility of the Criteria 
Concentrations, plus it permits the use of the most current 
toxicological data. Both estimates of chemical hazard derived 
through risk assessment and from AWQC are health—based numbers. The 
FDA criteria include consideration of other factors. 
 
Final judgement on degree of health risks and management of 
those hazards is made after consideration of the nature of the 
population exposed, their likely fish consumption patterns and the 
background concentrations of the chemicals in fish in the state. 
There are certain chemicals which are widely distributed in 
freshwater fish tissues within Massachusetts which generally are at 
or below the respective FDA Criteria concentrations for those 
chemicals, but which pose unacceptable health risks if judged by 
the Department’s risk management criteria. In instances such as 
this, ORS would try to determine if any particular species or age 
of fish had greater concentrations of the contaminant and then work 
with DPH to focus advisories on those species or size of fish. 
Historically, DPH has employed FDA Criteria as the evaluation 
standard for determining human health hazards from contaminated 
fish. ORS and DPH are working to improve the methodologies 
described above for assessing these risks and to integrate them 
into the Department’s risk management framework. 
 
 
 
3.2.2 Secondary Contact Evaluation 
 
Exposures to chemicals in surface waters not used as drinking 
water may occur as a result of the following processes: 
 
(1) incidental ingestion of surface water while swimming; 
(2) dermal contact with surface water; and 
(3) inhalation of chemicals that have volatilized from surface 
water. 
 
Typically, concentrations of volatile organic compounds (VOCs) 
in surface water bodies are relatively low due to their volatile 
nature and because of the large mixing volumes of water. In such 
cases, the relative risks from the dermal absorption and inhalation 
routes of exposure are often minor and insignificant compared to 
possible incidental ingestion exposures to contaminated surface 
water. 
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When ORS believes that secondary contact exposures could be 
significant routes of toxicity, the exposures are generally 
evaluated by the equations presented below. 
 
The Average Daily Dose received by an individual via 
contaminated surface water (ADDsw) is the sum of the ADDs for 
exposures resulting from incidental ingestion of the surface water 
(ADDswi), dermal contact with the contaminated surface water 
(ADDswd), and inhalation of chemicals volatilized from the surface 
water (ADDswih)  
 
   ADDsw =ADDswi + ADDswd + ADDswih 
 
 
 
 
3.2.2.1 Incidental Ingestion of Contaminated Surface Water. 
Intakes from incidental ingestion of surface water may happen while 
swimming in and during recreational use of a surface water body. 
The Average Daily Dose received via incidental ingestion of 
contaminated surface water (ADDswi) may be calculated using the 
equation presented for the ingestion of contaminated drinking water 
(ADDdwi) (Section 2.3.4). 
 
 
 
3.2.2.2 Dermal Contact With Contaminated Surface Water. Dermal 
contact with contaminated surface water may occur while wading, 
swimming, or during recreational use of surface water. The Average 
Daily Dose received via dermal absorption with contaminated surface 
water (ADDswd may be estimated by the following equation: 
 
 
 
  ADDswd = [Cont]sw * SA * PC * BAF * F * D1 * D2 * C 
                           BWavg * AP 
 
 
Where: 
 
 [Cont]sw = Representative concentration of contaminant 
   in the surface water during the period of 
   exposure (dimensions: mass/volume) 
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 SA = Skin surface area in contact with the surface 
   water during the period of exposure (dimension: 
   area) 
 
 PC = permeability Constant (dimensions: 
     volume/time*area) 
 
 BAF = Bioavailability Adjustment Factor 
 
 F = Number of exposure events during the exposure 
   period divided by the number of days in the 
   exposure period (dimensions: events/time 
    
 D1 = Average duration of each exposure event 
   (dimensions: time/event 
 
 D2 = Duration of the exposure period (dimension: 
   time) 
 
 BWavg = Average body weight of the individual exposed 
   during the averaging period (dimension: mass) 
 
 AP = Averaging period (dimension: time) 
 
 C = Appropriate units conversion factor(s) 
 
 
 
3.2.2.3 Inhalation of Contaminants Volatilized from Surface Water. 
Individuals may be exposed to chemicals in air by inhalation of 
chemicals in the vapor phase above contaminated surface water. The 
Average Daily Dose received via inhalation of chemicals volatilized 
from contaminated surface water (ADDdwih) may be estimated by using 
the equation presented for inhalation of chemicals volatilized from 
drinking water (ADDdwih) in Section 2.3.4. 
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